Agenus stock doubles as biotech narrows Phase 3 bet
Covered by 2 sources · 2 articles
2 outlets - including Yahoo and Thestreet - are covering this story. Agenus shares surged after the biotech secured upfront financing and shifted focus to a colon-cancer trial.
